Ionis Pharmaceuticals (IONS) P/S ratio

P/S ratio today
4.6×

Ionis Pharmaceuticals (IONS) trades at 4.6× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 13.4×. That is 80.4% higher than the 7.4× of fiscal 2024. Figures as of 18 Nov 2026, 04:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
4.6×
P/S ratio, fiscal 2025
13.4×
Change on fiscal 2024
+80.4%
Highest on record
29.9×fiscal 2013
Lowest on record
0.2×fiscal 2017
Fiscal years on record
172008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ionis Pharmaceuticals P/S ratio, in more detail

Today's figure is 65.9% below the fiscal 2025 year-end.

Across the 17 fiscal year-ends on record (2008–2025), the highest was 29.9× in fiscal 2013 and the lowest 0.2× in fiscal 2017. Today's P/S ratio is higher than at 6% of the 17 fiscal year-ends on record; their median is 9.2×.

History · 17 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Ionis Pharmaceuticals P/S ratio, year by year

Ionis Pharmaceuticals (IONS) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today4.6×—$26.96—
202513.4× 80.4% up$79.11$5.90
20247.4× 19.0% down$34.96$4.70
20239.2× 0.6% up$50.59$5.51
20229.1× 72.5% up$37.77$4.14
20215.3× 51.1% down$30.43$5.75
202010.8× 31.3% up$56.54$5.22
20198.2× 31.8% down$60.41$7.33
201812.1× 5,255.6% up$54.06$4.47
20170.2× 98.5% down$50.30$222.91
201615.5× 40.6% down$47.83$3.08
201526.1×—$61.93$2.37
2014——$61.74—
201329.9× 190.5% up$39.84$1.33
201210.3× 41.9% up$10.44$1.01
20117.3× 21.6% down$7.21$0.99
20109.2× 3.2% up$10.12$1.09
20099.0× 28.3% down$11.11$1.24
200812.5×—$14.18$1.13

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Ionis Pharmaceuticals and comparable companies
CompanyP/S ratio
LivaNova LIVN3.6×
Ionis Pharmaceuticals IONS4.8×
Dianthus Therapeutics DNTH2405.7×
MiniMed Group MMED1.6×
Adaptive Biotechnologies ADPT16.7×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on IONS

Ionis Pharmaceuticals, figure by figure

Ionis Pharmaceuticals (IONS) overview: price, valuation and scorecardAll health care companies by market value

Ionis Pharmaceuticals P/S ratio: questions and answers

What is Ionis Pharmaceuticals's P/S ratio?

Ionis Pharmaceuticals (IONS) trades at 4.6× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 13.4×. That is 80.4% higher than the 7.4× of fiscal 2024.

Is Ionis Pharmaceuticals's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 6% of the 17 fiscal year-ends on record; their median is 9.2×.

What are the highest and lowest P/S ratio figures on record for Ionis Pharmaceuticals?

Across the 17 fiscal year-ends on record (2008–2025), the highest was 29.9× in fiscal 2013 and the lowest 0.2× in fiscal 2017.

How is Ionis Pharmaceuticals's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ionis Pharmaceuticals (IONS) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IONS/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.